12 documents found, page 1 of 2
Is the association between Immunoglobulin A Nephropathy and Spondyloarthritis r...
Silva, S. P.; Rodrigues, M.; Ochôa Matos, C.; Nicolau, R.; Bernardes, M.; Santos Faria, M.; Eugénio, G.; Barcelos, A.Publisher Copyright: © 2025, Sociedade Portuguesa de Reumatologia. All rights reserved.; Spondyloarthritis is a group of inflammatory rheumatic diseases characterized by inflammation of the spine and sacroiliac joints. Extra-musculoskeletal manifestations may also occur, although kidney involvement is rarely reported. Immunoglobulin A nephropathy is one of the most common types of glomerulonephritis, and it can...
Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myo...
Silva, S. P.; Eugénio, G.; Pinto, M.; Barcelos, A.Publisher Copyright: © 2024 Sociedade Portuguesa de Reumatologia.; Anti-HMGCR myopathy is an increasingly recognized immune-mediated necrotizing myopathy. However, there are currently no evidence-based treatments available, so case reports and clinical experience are used to guide current management. We report a case of a 49-year-old man, treated with atorvastatin, who presented to the emergency department with...
Sex differences in axial spondyloarthritis
Cunha, R. N.; Sousa, E.; Khmelinskii, N.; Ávila, P.; Couto, M.; Seixas, M. I.; Martins, N.; Bernardes, M.; Martins, A.; da Silva, A. B.; Lourenço, M. H.Background: Axial spondyloarthritis (axSpA), particularly ankylosing spondylitis was historically considered a male’s disease and has been under-recognized in women. Emerging evidence reveals sex differences in pathophysiology, disease presentation and therapeutic efficacy. Objective: To identify differences between sexes in a Portuguese cohort of patients with axSpA regarding clinical manifestations, disease a...
Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic di...
Santos, Maria José; Canhão, Helena; Mourão, A. F.; Oliveira Ramos, F.; Ponte, C.; Duarte, C.; Barcelos, A.; Martins, F.; Melo Gomes, J. A.Patient registries are key instruments aimed at a better understanding of the natural history of diseases, at assessing the effectiveness of therapeutic interventions, as well as identifying rare events or outcomes that are not captured in clinical trials. However, the potential of registries goes far beyond these aspects. For example, registries promote the standardization of clinical practice, can also provid...
Portuguese recommendations for the use of biological therapies in patients with...
Machado, P. M.; Cerqueira, M.; Ávila-Ribeiro, P.; Aguiar, R.; Bernardo, A.; Sepriano, Alexandre; Águeda, A.; Cordeiro, A.; Raposo, A.; Rodrigues, A. M.Objective: To update the recommendations for the treatment of axial spondyloarthritis (axSpA) with biological therapies, endorsed by the Portuguese Society of Rheumatology. Methods: These treatment recommendations were formulated by Portuguese rheumatologists based on lite - rature evidence and consensus opinion. At a national meeting, the recommendations included in this document were discussed and updated. A ...
Portuguese recommendations for the use of biological therapies in patients with...
Duarte, Cátia; Sousa-Neves, J.; Águeda, A.; Ribeiro, P.; Daniel, A.; Eugénio, G.; Silvério Serra, Sofia; Araújo, F.; Barcelos, A.; Filipe, B.Objective: To update the recommendations for the treatment of rheumatoid arthritis (RA) with biological therapies, endorsed by the Portuguese Society of Rheu -matology (SPR). Methods: These treatment recommendations were formulated by Portuguese rheumatologists based on litera -ture evidence and consensus opinion. At a national meeting the 11 recommendations were discussed and updated. The document resulting fr...
Portuguese recommendations for the use of methotrexate in rheumatic diseases - ...
Duarte, Ana Catarina; Santos-Faria, D.; Gonçalves, M. J.; Sepriano, Alexandre; Mourão, A. F.; Duarte, C.; Neves, J. S.; Águeda, A. F.; Ribeiro, P. A.Background: Methotrexate (MTX) is the first-line drug in the treatment of rheumatoid arthritis (RA) and the most commonly prescribed disease modifying antirheumatic drug. Moreover, it is also used as an adjuvant drug in patients under biologic therapies, enhancing the efficacy of biologic agents. Objectives: To review the literature and update the Portuguese recommendations for the use of MTX in rheumatic disea...
Portuguese recommendations for the prevention, diagnosis and management of prim...
Maria Rodrigues, Ana; Canhão, Helena; Marques, A.; Ambrosio, C.; Borges, J.; S. Coelho, Pedro; Costa, L.; Fernandes, S.; Goncalves, I; Goncalves, M. J.
Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic di...
Santos, Maria José; Canhão, Helena; Mourão, A. F.; Ramos, F. O.; Ponte, C.; Duarte, C.; Barcelos, A.; Martins, F.; Melo Gomes, J. A.Patient registries are key instruments aimed at a better understanding of the natural history of diseases, at assessing the effectiveness of therapeutic interventions, as well as identifying rare events or outcomes that are not captured in clinical trials. However, the potential of registries goes far beyond these aspects. For example, registries promote the standardization of clinical practice, can also provid...
Portuguese recommendations for the use of biological therapies in patients with...
Machado, P.M.; Cerqueira, M.; Ávila-Ribeiro, P.; Aguiar, R.; Bernardo, A.; Sepriano, Alexandre; Águeda, A.; Cordeiro, A.; Raposo, A.Objective: To update the recommendations for the treatment of axial spondyloarthritis (axSpA) with biological therapies, endorsed by the Portuguese Society of Rheumatology. Methods: These treatment recommendations were formulated by Portuguese rheumatologists based on lite - rature evidence and consensus opinion. At a national meeting, the recommendations included in this document were discussed and updated. A ...